On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayJan 31, 2017 11:43 am

NetworkNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Positioned for Growth in $68.71B Market

Moxian, an offline-online (O2O) integrated platform operator, is set for growth in the booming O2O market. “Moxian, Inc. (NASDAQ: MOXC) is positioning itself as a leader in China’s O2O services market as the sector enjoys a 20% surge in year-over-year growth. iResearch Consulting Group, in its ‘2015 China Online-to-Offline (O2O) Services Model Research' … stated that the Chinese O2O market was on course to grow from $53.78 billion in 2015, to $68.71 billion in 2016. The report also forecast growth of 20% year-over-year through 2018 to more than $90 billion (http://nnw.fm/Jyj1C).” To view the full article, visit: http://nnw.fm/8XRdU About Moxian,…

Continue Reading

TuesdayJan 31, 2017 11:41 am

NetworkNewsBreaks – Sorrento Therapeutics, Inc. (NASDAQ: SRNE) Enriching Lives through Scientific Innovation

California-based biopharmaceutical company Sorrento Therapeutics (NASDAQ: SRNE) has a portfolio of OnTarget immunotherapies comprised of intracellular antibodies, immune checkpoint inhibitors, bispecific antibodies, and antibody-drug conjugates, as well as chimeric antigen receptor (CAR)-based cellular therapies. Through its TNK Therapeutics subsidiary, the company is also advancing adoptive cellular therapies utilizing the T cell as well as the Natural Killer cell. Sorrento has partnered with the City of Hope to form a joint venture, LA Cell, which is developing cell-internalizing mAbs against undruggable intracellular targets. Sorrento’s lead programs are four late-stage biosimilar and biobetter antibodies targeting an established market of more than $13…

Continue Reading

TuesdayJan 31, 2017 11:38 am

NetworkNewsBreaks – IsoRay, Inc. (NYSE: ISR) Initiates Pilot Study for Cesium-131 Impact on Head and Neck Cancer

Leading medical technology company IsoRay (NYSE: ISR) recently launched a new study to analyze the impact and safety of Cesium-131 brachytherapy seeds on recurrent neck and head cancer. The pilot study will be conducted at the Cleveland, Ohio, Case Western Reserve University’s Case Comprehensive Cancer Center, and it will begin enrollment of 42 subjects in early 2017. It is estimated that there are approximately 61,760 cases of neck and head cancer currently diagnosed in the United States. In case of recurrence, which happens with 30-40% of the cases, radiation therapy might not always be possible given the presence of vital…

Continue Reading

TuesdayJan 31, 2017 11:35 am

NetworkNewsBreaks – Amyris, Inc. (NASDAQ: AMRS) Making Technological Breakthroughs Under Guidance of Highly Experienced Management Team

Amyris (NASDAQ: AMRS) is one of the fastest growing industrial biotechnology companies among the 2,772 in the U.S today. The company’s seven-person management team is made up of hand-picked individuals with a proven ability to innovate and build companies in a number of industries. With over 30 years of experience as a tech entrepreneur and thought leader, president and CEO John Melo has led Amyris from technology development and industrial startup to product development and final commercialization. Thanks to the team’s level of experience, Amyris has made outstanding technological breakthroughs, among these is the world’s leading treatment for malaria, saving…

Continue Reading

TuesdayJan 31, 2017 11:33 am

NetworkNewsBreaks – Provision Holding (PVHO) Positioned as Leading Purveyor of 3D Holographic Technology

Provision Holding (OTC: PVHO) provides three-dimensional (3D) holographic display technologies, software and integrated solutions for both commercial and consumer-focused applications. Provision’s patented, interactive displays are built on proprietary technology to deliver “3D Holographic Media” – without the use of special glasses – to target audiences. The company’s early line of display systems is ideally suited for indoor and outdoor point-of-sale, merchandising and point of sale-related advertising venues. Recently, the company launched version 2.0 of its advanced 3D Savings Center software. The application-based platform delivers a comprehensive solution to consumers in retail stores while remaining user-friendly with an enhanced loyalty card…

Continue Reading

TuesdayJan 31, 2017 11:30 am

NetworkNewsBreaks – Strong IP, Key Partnerships Drive RegeneRx Biopharmaceuticals, Inc. (RGRX) Growth

RegeneRx (OTCQB: RGRX) is a clinical-stage biopharmaceutical company with a large, growing patent portfolio that protects multiple indications and applications for its product candidates. At the heart of its IP strategy is Thymosin Beta 4 (Tβ4), a naturally occurring peptide found to play a vital role in protection, regeneration and remodeling of damaged tissues. RegeneRx is currently moving three distinct Tβ4-based drug candidates through clinical development for ophthalmic, cardiac and dermal indications. The company recently received notice of Intent to Grant a patent from the European Patent Office for treating neural injury using Tβ4. More recently, the company received patent…

Continue Reading

TuesdayJan 31, 2017 10:50 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) to Acquire Stake in Convectium, Creator of Cannabis Industry’s First-of-its-Kind Oil Filling Machine

SinglePoint (OTC: SING), a full-service mobile technology and marketing provider, this morning announced its LOI to acquire an interest in Convectium, the creator of a unique oil filling machine capable of filling cartridges or disposable vape pens for wholesale distribution to dispensaries. Convectium’s 710Shark and 710Seal system can fill and package up 100+ cartridges or disposable vape pens in 30 seconds. “To say we are excited about this opportunity is an understatement. Convectium's 710Shark and 710Seal system is incredible, and its capabilities are unmatched. After looking at hundreds of cannabis companies, finding an acquisition opportunity like we have found in…

Continue Reading

TuesdayJan 31, 2017 10:48 am

NetworkNewsBreaks – International IT Security Company Selects Net Element’s (NASDAQ: NETE) PayOnline as Secure Payments Provider

Shares of Net Element (NASDAQ: NETE) are inching higher after the provider of global mobile payment technology said ESET, an international IT security company offering anti-virus and firewall products, has chosen PayOnline to provide secure payment acceptance services in Kazakhstan. The contract demonstrates PayOnline’s growing position as a domestic and international partner for companies looking for a secure payments platform. "Complex technology can be available, understandable and user-friendly. We believe in it and select partners whose values are similar to ours. Accepting payments at ESET online store utilizing PayOnline fully meets our requirements for quality of service and reliability. We…

Continue Reading

TuesdayJan 31, 2017 10:45 am

NetworkNewsBreaks – Stealth Technologies, Inc. (STTH) Provides Summary of Key Initiatives, Achievements in 2016

Stealth Technologies (OTCQB: STTH) this morning issued a summary of several successful growth and development initiatives in 2016, and how those achievements position the company moving forward. Stealth Technologies completed a name and ticker symbol change in conjunction with its transition to a technology-driven company focused on IP, product development and sales within the personal, financial and data security markets. Highlights include: Sales in excess of 221,000 units of its flagship product, Stealth Card, which protects consumers against "electronic pickpocketing" of credit cards; Sales in excess of 64,000 units of the 911 Help Now product, which allows consumers instant two-way…

Continue Reading

MondayJan 30, 2017 3:22 pm

NetworkNewsBreaks – EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) Shares Higher on Encouraging Top-line Data from Trial of Ocular Bandage Gel

Shares of EyeGate Pharmaceuticals (NASDAQ: EYEG) are up more than 15% mid-day following topline results from the first-in-human pilot trial of the company’s EyeGate Ocular Bandage Gel (EyeGate OBG) in corneal epithelial effects. The study enrolled 39 subjects undergoing bilateral photorefractive keratectomy surgery to assess the safety and performance of EyeGate OBG on its own or combined with a bandage contact lens (BCL) compared to the current standard of care, artificial tears and BCL. The study demonstrated safety and tolerability of EyeGate OBG, with encouraging potential efficacy. “Corneal epithelial defects represent a large, underserved market with no approved eye drops…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217